Clinical Trial Update: Tacrolimus as Treatment of Breast Cancer-Related Lymphedema [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates Tacrolimus as a treatment for breast cancer-related lymphedema across Phase 1 and Phase 2; study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer-related Lymphedema

Drugs mentioned

• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Odense University Hospital | Conditions: Breast Cancer Lymphedema | Phase 1, Phase 2 | Status: COMPLETED